tiprankstipranks
Trending News
More News >
Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market

Tyra Bioscience (TYRA) Financial Statements

Compare
119 Followers

Tyra Bioscience Financial Overview

Tyra Bioscience's market cap is currently $1.78B. The company's EPS TTM is $-0.57; its P/E ratio is -17.56; Tyra Bioscience is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -132.76M$ -104.18M$ -79.94M$ -58.93M$ -26.29M
EBITDA$ -119.40M$ -103.66M$ -79.59M$ -58.63M$ -26.15M
Net Income$ -119.95M$ -86.48M$ -69.13M$ -55.33M$ -26.29M
Balance Sheet
Cash & Short-Term Investments$ 256.00M$ 341.44M$ 203.47M$ 251.21M$ 302.18M
Total Assets$ 282.61M$ 363.56M$ 225.86M$ 266.18M$ 306.70M
Total Debt$ 5.81M$ 6.22M$ 6.50M$ 2.62M$ 1.18M
Net Debt$ -71.58M$ -85.74M$ -51.51M$ -248.59M$ -301.00M
Total Liabilities$ 23.43M$ 20.41M$ 21.59M$ 8.35M$ 4.96M
Stockholders' Equity$ 259.18M$ 343.15M$ 204.26M$ 257.83M$ 301.74M
Cash Flow
Free Cash Flow$ -95.28M$ -70.44M$ -50.91M$ -50.84M$ -24.41M
Operating Cash Flow$ -95.14M$ -69.77M$ -50.14M$ -50.28M$ -23.75M
Investing Cash Flow$ 72.46M$ -98.40M$ -144.60M$ -559.00K$ -645.00K
Financing Cash Flow$ 8.10M$ 202.14M$ 1.54M$ 632.00K$ 311.35M
Currency in USD

Tyra Bioscience Earnings and Revenue History

Tyra Bioscience Debt to Assets

Tyra Bioscience Cash Flow

Tyra Bioscience Forecast EPS vs Actual EPS